According to the Zacks Investment Research report, Equities analysts forecast that Imperva, Inc. (NYSE:$IMPV) will see sales of $83.07 million for the current quarter. Seven analysts have issued estimates for Imperva’s earnings.
The lowest sales estimate is at $82.01 million and the highest is $83.80 million. Similarly, Imperva reported sales of $68.41 million during the same quarter last year, which would indicate a positive year-over-year growth rate of 21.4%
On average, analysts are speculating for Imperva to report full-year sales of $83.07 million for the current fiscal year, with estimates ranging from $320.90 million to $324.02 million. For the upcoming fiscal year, analysts anticipate that the company will post sales of $379.96 million per share, with estimates ranging from $369.00 million to $386.30 million.
Further, many equities research analysts have recently commented on Imperva shares. Monness Crespi & Hardt lifted their price target on shares of Imperva from $55.00 to $57.00 and granted the stock a “buy” rating in a research report posted in July. Similarly, Evercore ISI granted the stock a $56.00 price target on top of a “Buy” rating.
Imperva Inc provides cyber-security solutions that protect business-critical data and applications. The company is engaged in the development, marketing, sales, services, and support of cyber-security solutions.
Featured Image: twitter
